Cargando…

Urine cell-free DNA is a biomarker for nephroblastomatosis or Wilms Tumor in PIK3CA-related overgrowth spectrum (PROS)

PURPOSE: We set out to facilitate the molecular diagnosis of patients with PIK3CA-related overgrowth spectrum (PROS), a heterogeneous somatic disorder characterized by variable presentations of segmental overgrowth, vascular malformations, skin lesions, and nephroblastomatosis, rare precursor lesion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waberski, Marta Biderman, Lindhurst, Marjorie, Keppler-Noreuil, Kim M., Sapp, Julie C., Baker, Laura, Gripp, Karen W., Adams, Denise M., Biesecker, Leslie G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365240/ https://www.ncbi.nlm.nih.gov/pubmed/29300373 http://dx.doi.org/10.1038/gim.2017.228

Ejemplares similares

Clinical Delineation and Natural History of the PIK3CA-Related Overgrowth Spectrum**
por: Keppler-Noreuil, Kim M, et al.
Publicado: (2014)

Nephroblastomatosis and wilms tumor: dangerous liaisons
por: de Jesus, Lisieux Eyer, et al.
Publicado: (2020)

Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the PIK3CA-related overgrowth spectrum
por: Koutlas, Ioannis G., et al.
Publicado: (2021)

Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the PIK3CA-related overgrowth spectrum
por: Koutlas, Ioannis G., et al.
Publicado: (2020)

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
por: Parker, Victoria E. R., et al.
Publicado: (2018)

Prognostic Factors of Wilms’ Tumor Complicated with Nephroblastomatosis
por: Niu, Hong-Chuan, et al.
Publicado: (2015)

PIK3CA-related overgrowth spectrum (PROS) presenting as isolated macrodactyly
por: Krishnamurthy, Kritika, et al.
Publicado: (2023)

PIK3CA-Related Overgrowth Syndrome (PROS) and Angiosarcoma: A Case Report
por: Weinstein, Brielle, et al.
Publicado: (2020)

PIK3CA-related overgrowth spectrum (PROS): a rare case report
por: Kalo, Cedra, et al.
Publicado: (2023)

Clinical Profile of Overgrowth Syndromes Consistent with PROS (PIK3CA-Related Overgrowth Syndromes)—A Case Series
por: Mathew, Lydia, et al.
Publicado: (2020)

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
por: Canaud, Guillaume, et al.
Publicado: (2021)

Lymphangioma of the fetal neck within the PIK3CA‐related‐overgrowth spectrum (PROS): A case report
por: Scharf, Jann Lennard, et al.
Publicado: (2021)

Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth
por: Cottrell, Catherine E., et al.
Publicado: (2021)

Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
por: Rodríguez-Laguna, Lara, et al.
Publicado: (2022)

One of the First Cases with PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review
por: Alsaedi, Saleem A, et al.
Publicado: (2020)

Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30‐year SIOP‐RTSG experience
por: Hol, Janna A., et al.
Publicado: (2020)

Case report: Diffuse hyperplastic perilobar nephroblastomatosis complicated by a unilateral Wilms tumour: diagnosis, treatment and follow-up
por: Gao, Bruce, et al.
Publicado: (2018)

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018)

Perilobar Nephroblastomatosis: Natural History and Management
por: Stabouli, S., et al.
Publicado: (2014)

Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis: Mapping the Way to Understanding Wilms’ Tumor Development and Differential Diagnosis
por: Csók, Ádám, et al.
Publicado: (2023)

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
por: Ranieri, C., et al.
Publicado: (2018)

PIK3CA-related overgrowth with an uncommon phenotype: case report
por: Rotunno, Roberta, et al.
Publicado: (2022)

Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
por: Loconte, Daria C., et al.
Publicado: (2015)

Brain tissue- and region-specific abnormalities on volumetric MRI scans in 21 patients with Bardet-Biedl syndrome (BBS)
por: Keppler-Noreuil, Kim M, et al.
Publicado: (2011)

The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)
por: Suzuki, Yasuyo, et al.
Publicado: (2017)

Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
por: Morin, Gabriel, et al.
Publicado: (2022)

Extrarenal nephroblastomatosis in children: a report of two cases
por: Wu, Yi, et al.
Publicado: (2014)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

Acute Lymphocytic Leukemia with Bilateral Renal Masses Masquerading as Nephroblastomatosis
por: Thakore, Poonam, et al.
Publicado: (2015)

Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences
por: Dexheimer, Joy, et al.
Publicado: (2022)

Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With PIK3CA-Related Overgrowth Spectrum
por: Nasomyont, Nat, et al.
Publicado: (2023)

Letter to editor: Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the PIK3CA-related overgrowth spectrum
por: Maldonado, Andrés A., et al.
Publicado: (2022)

Bilateral Renal Dysplasia, Nephroblastomatosis, and Bronchial Stenosis. A New Syndrome?
por: Rodriguez, Maria Matilde, et al.
Publicado: (2015)

Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments
por: Raymond, Kimberly, et al.
Publicado: (2022)

Mouse models of human PIK3CA-related brain overgrowth have acutely treatable epilepsy
por: Roy, Achira, et al.
Publicado: (2015)

Segmental epidermal nevus and mucosal neuromas associated with PIK3CA-related overgrowth spectrum disorder
por: Roth, Gretchen M., et al.
Publicado: (2018)

Somatic non-cancerous PIK3CA-related overgrowth syndrome treated with alpelisib in North America
por: Garneau, Alexandre P., et al.
Publicado: (2021)

Exome sequencing identifies novel mutations in C5orf42 in patients with Joubert syndrome with oral–facial–digital anomalies
por: Wentzensen, Ingrid M, et al.
Publicado: (2015)

Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth
por: Frisk, Sofia, et al.
Publicado: (2019)

Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
por: Forde, Karina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abs6sh8ven4q86hkd9913cokap